Core Laboratories NV (NYSE: CLB) suffers from meaningful negative changes in investment behavior: negative upside/downside volume developed.
Recent significant negative changes in fundamentals have impacted Core Laboratories NV (NYSE: CLB): the consensus estimate for December, 2023 decreased significantly, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2024 decreased significantly.
In light of these highly negative signals we are reviewing our current Overall Rating of D. We would continue to view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, CLB is expected to continue to be a major Value Builder.
Core Laboratories has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Core Laboratories has a poor Appreciation Score of 17 but a slightly positive Power Rating of 68, producing the Negative Value Trend Rating.
Recent Price Action
Core Laboratories NV (NYSE: CLB) stock enjoyed a large increase of 2.0% on 12/1/23. The stock closed at $18.07. Trading volume in this advance was normal. The stock has performed in line with the market over the last nine months and has declined -0.7% during the last week.
Be the first to comment